US Broker Ratings

Gilead Sciences (GILD) Stock Analysis: Key Insights on Growth, Dividends, and Analyst Ratings

Gilead Sciences, Inc. (GILD) stands as a prominent player in the healthcare sector, primarily focused on the drug manufacturing industry. With a market capitalization of $150.88..

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with a 23% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), headquartered in Dublin, Ireland, is a prominent player in the biotechnology sector, renowned for its innovative drug portfolio aimed at addressing..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring Growth Potential with a $110 Billion Market Cap

HCA Healthcare, Inc. (HCA) has firmly established itself as a powerhouse within the medical care facilities industry, boasting an impressive market capitalization of $110.07 billion. As..

Merck & Co., Inc. (MRK) Investor Outlook: Strong Buy Ratings and Promising Upside

As one of the prominent players in the healthcare sector, Merck & Co., Inc. (NYSE: MRK) continues to capture investor attention with its robust portfolio and..

Chemed Corp (CHE) Investor Outlook: Analysts Eye 35.50% Upside Potential

Chemed Corp (NYSE: CHE), a key player in the healthcare sector with a focus on medical care facilities, presents an intriguing proposition for investors seeking both..

Qiagen N.V. (QGEN) Stock Analysis: Navigating a 11.91% Potential Upside in Healthcare Diagnostics

Qiagen N.V. (NYSE: QGEN) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Based in Venlo, the Netherlands, this $9.8..

Teva Pharmaceutical Industries (TEVA) Stock Report: Analyst Consensus Points to 8.24% Upside Potential

Teva Pharmaceutical Industries Limited (NYSE: TEVA) stands as a formidable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a..

UnitedHealth Group (UNH) Stock Analysis: Understanding the 16.6% Potential Upside for Investors

Investors looking for stability and growth in the healthcare sector need look no further than UnitedHealth Group Incorporated (NYSE: UNH). As a heavyweight in the healthcare..

GSK plc (GSK) Stock Analysis: Evaluating the Healthcare Giant’s Potential with a Robust 41.52% ROE

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, continues to attract the attention of investors with its diverse portfolio and a strong presence in..

Agilent Technologies (A): Analyzing Growth Potential with a 22% Upside in the Diagnostics Arena

Agilent Technologies, Inc. (NYSE: A), a venerable name in the healthcare sector, particularly within the diagnostics and research industry, is capturing investor attention with its strong..

Medpace Holdings, Inc. (MEDP) Investor Outlook: Navigating a 23.70% Revenue Growth in the Healthcare Sector

Investors eyeing the healthcare sector have likely noticed Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the diagnostics and research industry. Based in Cincinnati, Ohio,..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 56.85% Potential Upside in the Healthcare Sector

Doximity, Inc. (NASDAQ: DOCS) is capturing investor attention with its robust digital platform tailored for healthcare professionals. As of its latest market snapshot, Doximity boasts a..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Powerhouse with 22% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology sector, drawing attention from investors with its remarkable growth potential and strong analyst support. Based..

AbbVie Inc. (ABBV) Stock Analysis: Unpacking Growth with a Robust 6.70% Potential Upside

AbbVie Inc. (NYSE: ABBV), a titan in the biopharmaceutical sector, continues to captivate investor interest with its impressive market presence and potential for future growth. With..

Smith & Nephew SNATS, Inc. (SNN) Investor Outlook: Exploring a Promising 11.41% Upside Potential

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, continues to draw attention from investors with its robust market presence and significant..

ICON plc (ICLR) Investor Outlook: Analyzing Upside Potential and Market Position

ICON plc (NASDAQ: ICLR) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Dublin, Ireland, ICON specializes..

West Pharmaceutical Services, Inc. (WST): Investor Outlook Reveals 25% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST) stands out as a compelling opportunity in the healthcare sector, particularly within the niche of medical instruments and supplies. With..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 31.74% Potential Upside in the Healthcare Sector

Investors in AptarGroup, Inc. (NYSE: ATR) are eyeing a significant potential upside, with analysts suggesting a 31.74% increase from the current price of $122.54 to an..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 33% Potential Upside for Investors

For investors seeking opportunities in the healthcare sector, HealthEquity, Inc. (NASDAQ: HQY) presents an intriguing proposition. With a market capitalization of $7.88 billion, HealthEquity stands at..

Elevance Health, Inc. (ELV) Stock Report: Analyzing Growth Potential with a 9.87% Upside

Investors eyeing the healthcare sector should take a closer look at Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds